228 related articles for article (PubMed ID: 24937960)
1. Histopathological and immunohistochemical features of early hydatidiform mole in relation to subsequent development of persistent gestational trophoblastic disease.
Petts G; Fisher RA; Short D; Lindsay I; Seckl MJ; Sebire NJ
J Reprod Med; 2014; 59(5-6):213-20. PubMed ID: 24937960
[TBL] [Abstract][Full Text] [Related]
2. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
[TBL] [Abstract][Full Text] [Related]
3. Loss of p57 Expression in Conceptions Other Than Complete Hydatidiform Mole: A Case Series With Emphasis on the Etiology, Genetics, and Clinical Significance.
Xing D; Miller K; Beierl K; Ronnett BM
Am J Surg Pathol; 2022 Jan; 46(1):18-32. PubMed ID: 34074808
[TBL] [Abstract][Full Text] [Related]
4. [Risk factors for gestational trophoblastic tumors following complete hydatidiform mole].
Grzybowski W; Płoszyński A; Mielnik J; Adamcio-Deptulska M; Preis K; Wojciechowska D
Ginekol Pol; 2002 Nov; 73(11):1003-10. PubMed ID: 12722390
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia.
Braga A; Maestá I; Rocha Soares R; Elias KM; Custódio Domingues MA; Barbisan LF; Berkowitz RS
Am J Obstet Gynecol; 2016 Sep; 215(3):336.e1-336.e12. PubMed ID: 27094961
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic aspects of hydatidiform mole with persistence of polymorphic trophoblastic hyperplasia.
Makovitzky J; Vogel M; Miessner R; Mylonas I; Vogt-Weber B; Richter DU
Anticancer Res; 2003; 23(2A):1069-73. PubMed ID: 12820349
[TBL] [Abstract][Full Text] [Related]
7. p53 expression in placentas with hydropic change and hydatidiform moles.
Cheville JC; Robinson RA; Benda JA
Mod Pathol; 1996 Apr; 9(4):392-6. PubMed ID: 8729978
[TBL] [Abstract][Full Text] [Related]
8. Complete hydatidiform mole with retained maternal chromosomes 6 and 11.
McConnell TG; Norris-Kirby A; Hagenkord JM; Ronnett BM; Murphy KM
Am J Surg Pathol; 2009 Sep; 33(9):1409-15. PubMed ID: 19542869
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of LMP2 and PPM1A in gestational trophoblastic disease].
Zhang SS; Wan XY; Zhou CY; Lü WG; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):510-5. PubMed ID: 22041443
[TBL] [Abstract][Full Text] [Related]
10. Hydatidiform moles: ancillary techniques to refine diagnosis.
Ronnett BM; DeScipio C; Murphy KM
Int J Gynecol Pathol; 2011 Mar; 30(2):101-16. PubMed ID: 21293291
[TBL] [Abstract][Full Text] [Related]
11. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
Niemann I; Hansen ES; Sunde L
Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
[TBL] [Abstract][Full Text] [Related]
12. Pathology of gestational trophoblastic diseases.
Cheung AN
Best Pract Res Clin Obstet Gynaecol; 2003 Dec; 17(6):849-68. PubMed ID: 14614885
[TBL] [Abstract][Full Text] [Related]
13. Histomorphometric features of hydatidiform moles in early pregnancy: relationship to detectability by ultrasound examination.
Fowler DJ; Lindsay I; Seckl MJ; Sebire NJ
Ultrasound Obstet Gynecol; 2007 Jan; 29(1):76-80. PubMed ID: 17171630
[TBL] [Abstract][Full Text] [Related]
14. [Trophoblastic disease. II. Immunohistochemical and cytogenetic parameters of partial hydatidiform moles].
Danihel L; Porubský J; Vojtassák J; Breitenecker G
Cesk Patol; 1994 Aug; 30(3):80-4. PubMed ID: 7923421
[TBL] [Abstract][Full Text] [Related]
15. [Gestational trophoblastic disease, Villous gestational trophoblastic disease].
Vogel M; Horn LC
Pathologe; 2004 Jul; 25(4):269-79. PubMed ID: 15197483
[TBL] [Abstract][Full Text] [Related]
16. Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome.
Hancock BW; Nazir K; Everard JE
J Reprod Med; 2006 Oct; 51(10):764-6. PubMed ID: 17086803
[TBL] [Abstract][Full Text] [Related]
17. p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles.
Jun SY; Ro JY; Kim KR
Histopathology; 2003 Jul; 43(1):17-25. PubMed ID: 12823708
[TBL] [Abstract][Full Text] [Related]
18. Histopathological diagnosis of hydatidiform mole: contemporary features and clinical implications.
Sebire NJ
Fetal Pediatr Pathol; 2010; 29(1):1-16. PubMed ID: 20055560
[TBL] [Abstract][Full Text] [Related]
19. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
Kale A; Söylemez F; Ensari A
Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologists.
Gupta M; Vang R; Yemelyanova AV; Kurman RJ; Li FR; Maambo EC; Murphy KM; DeScipio C; Thompson CB; Ronnett BM
Am J Surg Pathol; 2012 Dec; 36(12):1747-60. PubMed ID: 22992698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]